Literature DB >> 26166321

Dual-modular molecular imaging to trace transplanted bone mesenchymal stromal cells in an acute myocardial infarction model.

Jian Cao1, Xiao Li1, Ning Chang1, Yining Wang2, Jing Lei1, Dachun Zhao3, Kai Gao4, Zhengyu Jin5.   

Abstract

BACKGROUND AIMS: The purpose of the study was to investigate the feasibility of in vitro and in vivo bioluminescence imaging (BLI), fluorescence imaging (FI) and magnetic resonance imaging (MRI) to trace transplanted bone mesenchymal stromal cells (BMSCs) labeled with the firefly luciferase (Fluc) reporter gene, CyI dyes and ultra-small super-paramagnetic iron oxide (USPIO) particles.
METHODS: Fluc-transfected BMSCs were further labeled with CyI dyes and USPIO particles, respectively. Acute myocardial infarction models of different weighted Sprague-Dawley rats and Balb/c mice were established, and BLI and FI were performed in vivo and ex vivo to determine the optimal method of optical imaging. Finally, BLI and MRI were selected to trace transplanted BMSCs in a murine model in vivo.
RESULTS: BLI was found to be the optimal optical imaging method in vivo, compared with FI, and mice were found to be the optimal animal model, compared with rats. A significant BLI signal intensity was detected in the heart region in the BMSC-treated mice group (40,552 ± 6073 counts, n = 26) and gradually decreased below the detection threshold. Two distinct hypo-intense regions were observed in the anterior wall of the heart, where stem cells were injected on MR images obtained with the gradient recalled echo cine sequence in the BMSC-treated mice group.
CONCLUSIONS: Transplanted BMSCs labeled with Fluc reporter gene and USPIO particles can be traced with the use of BLI and MRI in a mouse model of acute myocardial infarction.
Copyright © 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  bioluminescence imaging; bone mesenchymal stromal cells; firefly luciferase; magnetic resonance imaging; ultra-small super-paramagnetic iron oxide

Mesh:

Substances:

Year:  2015        PMID: 26166321     DOI: 10.1016/j.jcyt.2015.05.003

Source DB:  PubMed          Journal:  Cytotherapy        ISSN: 1465-3249            Impact factor:   5.414


  7 in total

Review 1.  Stem Cell Monitoring with a Direct or Indirect Labeling Method.

Authors:  Min Hwan Kim; Yong Jin Lee; Joo Hyun Kang
Journal:  Nucl Med Mol Imaging       Date:  2015-10-22

2.  Multimodality imaging in the assessment of bone marrow-derived mesenchymal stem cell therapy for doxorubicin-induced cardiomyopathy.

Authors:  Chanjuan Qu; Jian Wang; Yuqing Wang; Fangfei He; Xudong Shi; Zhuoli Zhang; Yining Wang
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

Review 3.  Iron Oxide Nanoparticles in Regenerative Medicine and Tissue Engineering.

Authors:  Ralf P Friedrich; Iwona Cicha; Christoph Alexiou
Journal:  Nanomaterials (Basel)       Date:  2021-09-08       Impact factor: 5.719

4.  Image-guided stem cells with functionalized self-assembling peptide nanofibers for treatment of acute myocardial infarction in a mouse model.

Authors:  Xiao Li; Ying-Ying Chen; Xiu-Mei Wang; Kai Gao; Yun-Zhou Gao; Jian Cao; Zhuo-Li Zhang; Jing Lei; Zheng-Yu Jin; Yi-Ning Wang
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

5.  Embryonic stem cell-derived cardiomyocytes for the treatment of doxorubicin-induced cardiomyopathy.

Authors:  Danúbia Silva Dos Santos; Guilherme Visconde Brasil; Isalira Peroba Rezende Ramos; Fernanda Cristina Paccola Mesquita; Tais Hanae Kasai-Brunswick; Michelle Lopes Araújo Christie; Gustavo Monnerat Cahli; Raiana Andrade Quintanilha Barbosa; Sandro Torrentes da Cunha; Jonathas Xavier Pereira; Emiliano Medei; Antonio Carlos Campos de Carvalho; Adriana Bastos Carvalho; Regina Coeli Dos Santos Goldenberg
Journal:  Stem Cell Res Ther       Date:  2018-02-05       Impact factor: 6.832

6.  Delivery of bevacizumab by intracranial injection: assessment in glioma model.

Authors:  Yu-Xiao Liu; Wen-Jia Liu; Hui-Ru Zhang; Zhi-Wen Zhang
Journal:  Onco Targets Ther       Date:  2018-05-08       Impact factor: 4.147

7.  Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy.

Authors:  Guilherme Visconde Brasil; Danúbia Silva Dos Santos; Elias Ataide Mendonça; Fernanda Cristina Paccola Mesquita; Tais Hanae Kasai-Brunswick; Sandro Torrentes da Cunha; Cibele Ferreira Pimentel; Andréia de Vasconcelos-Dos-Santos; Rosália Mendez-Otero; Clério Francisco de Azevedo Filho; Regina Coeli Dos Santos Goldenberg; Antonio Carlos Campos de Carvalho
Journal:  Cells       Date:  2020-07-07       Impact factor: 6.600

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.